Park Square Executive Search

Exogenesis Corporation Appoints Dmitry Shashkov as President and CEO

The Board of Directors of Exogenesis Corporation ( is pleased to announce the appointment of Dmitry Shashkov, Ph.D. as President and Chief Executive Officer.

UC San Diego Names Erik T. Mitchell New Audrey Geisel University Librarian

Erik T. Mitchell, Ph.D. has been appointed university librarian at the University of California San Diego effective April 16, 2018. Mitchell currently serves as associate university librarian of Digital Initiatives and Collaborative Services and associate chief information officer at UC Berkeley.

Threat Stack Appoints Aditya Joshi as EVP of Products and Technology

Threat Stack, provider of the industry’s most comprehensive intrusion detection platform for cloud, hybrid-cloud, and on-premises environments, today announced that it has appointed Aditya Joshi (AJ) as the company’s Executive Vice President of Products and Technology. 

Threat Stack Announces Jonaki Egenolf as CMO

Threat Stack, provider of the industry’s most comprehensive intrusion detection platform for cloud, hybrid-cloud, and on-premise environments, today announced two major additions to its leadership team. Jonaki Egenolf has been named the company’s first Chief Marketing Officer, while Chris Ford joins as Vice President of Product. 

Melinta Therapeutics Announces Successful Completion of Merger

Melinta Therapeutics Inc. (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, announced that concurrent with the closing of the merger, the board will add Jay Galeota, a pharmaceutical veteran who has held diverse key leadership positions including chief strategy and business development officer and president, emerging businesses at Merck & Co. Inc., and who is currently the president and chief operating officer of G&W Laboratories, Inc. 

Interactions Announces Robert Nagle as Chief Technology Officer and Chief Product Officer

Interactions, LLC, a leading provider of Intelligent Virtual Assistants (IVAs) for enterprise customer care, today announced Robert Nagle has joined the company as Chief Technology Officer and Chief Product Officer.

Melinta and Cempra Name Industry Leader Daniel Wechsler as President and Chief Executive Officer of the Combined Company

Melinta Therapeutics, Inc., a privately held company developing and commercializing novel antibiotics to treat serious bacterial infections, and Cempra, Inc. (Nasdaq:CEMP) today announced that their joint chief executive officer (CEO) selection committee has selected Dan Wechsler to be president and CEO and a member of the board of directors of the combined company.

Colt hires ex-Windstream and XO exec Randy Nicklas

Colt has appointed Randy Nicklas, former CTO of XO Communications and then Windstream in the US, as its vice president of network engineering.

Oxford Immunotec Appoints Richard Wenstrup, MD, as Chief Medical Officer

Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced the appointment of Richard Wenstrup, MD, as Chief Medical Officer.

Revolution Growth Adds New Partner Todd Klein, Promotes Steve Murray to Managing Partner, Names Evan Morgan Special Partner

Today Revolution Growth, Revolution’s growth-stage investment fund launched by Steve Case, Ted Leonsis, and Donn Davis, announced further expansion of its team following the closing of its $525 million Revolution Growth III fund last year. The changes include the addition of a new Partner, Todd Klein; the promotion of Steve Murray to Managing Partner and Evan Morgan to Special Partner; and the addition of Luisa Sucre as Analyst.

Cognoa Hires Vice President of Medical, Further Advancing Developmental Diagnosis Technology

Sharief Taraman, MD, joins Cognoa as vice president of medical, bringing experience in pediatric neurology and leading Cognoa's healthcare and data science expansion.

Histogenics Corporation Announces the Appointment of Donald Haut, Ph.D. as Chief Business Officer

Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, announced the appointment of Donald Haut, Ph.D. as its Chief Business Officer. 

Neil Guterman Named Dean of The Silver School of Social Work

NYU President Andrew Hamilton and Provost Katherine E. Fleming today named Neil Guterman, a nationally recognized expert on child abuse and neglect and child victimization, as dean of NYU's Silver School of Social Work, effective September 1, 2017.

Zymergen Enhances R&D Leadership with Key Hires

Zymergen, Inc., a technology company focused on leveraging automation and computational tools to engineer microbes, has hired several new senior staff to lead and continue to develop the company’s research, development, and automation functions. These key additions are: David McLoughlin, Ph.D., Vice President of Automation; Jeff Touchman, Ph.D., Vice President of Metabolic Engineering; and Vytas SunSpiral, Director of Advanced Technology. 

Brodl Named Provost at Illinois Wesleyan University

Mark Brodl, currently Associate Vice President for Academic Affairs: Budget and Research at Trinity University in San Antonio, Texas, has been named the next provost of Illinois Wesleyan University, effective July 17.

Page 1 of 14 pages  1 2 3 >  Last ›